Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
COVAP
1 other identifier
observational
22
1 country
1
Brief Summary
A Respiratory infection with the SARS-CoV2 virus is associated with a major risk of viral pneumonia that can lead to respiratory distress requiring resuscitation. In the most severe forms, it may require mechanical ventilation or even lead to an acute respiratory distress syndrome with a particularly poor prognosis. The SARS-CoV2 is a single-stranded RNA virus of positive polarity and belongs to the beta genus of Coronaviruses. SARS-CoV2 is responsible for the third epidemic in less than twenty years secondary to a Coronavirus (SARS-CoV then MERS-CoV) and if the mortality associated with it is lower than that of previous strains, notably MERS-CoV, its spread is considerably big. As a result, the number of patients developing respiratory distress requiring invasive mechanical ventilation is high, with prolonged ventilation duration in these situations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2020
CompletedStudy Start
First participant enrolled
September 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedMarch 7, 2023
March 1, 2023
2 years
July 23, 2020
March 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Research of the bacteria responsible for nosocomial pneumonia
Establishing a biobank of the bacterial agents responsible for nosocomial pneumonia acquired under mechanical ventilation in order to: better understand the particularities of the bacteria responsible and obtain the "clinical" strains for in vitro studies that will be carried out secondarily.
6 months
Secondary Outcomes (1)
Additional evaluations to the study
6 months
Eligibility Criteria
Patient aged over 18 years, infected by the COVID-19 with a severe form of pneumonia especially the nosocomial pneumonia acquired under mechanical ventilation.
You may qualify if:
- Patient whose age ≥ 18 years old
- French-speaking patient
- Patient whose COVID-19 infection was diagnosed by either a laboratory test, PCR or any other commercial or public health test.
- Adult acute respiratory distress syndrome according to the Berlin definition
- Pneumonia acquired under mechanical ventilation defined according to the criteria of international companies
You may not qualify if:
- Patient/family or proxy opposing participation in the study
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under the safeguard of justice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondation Hôpital Saint-Josephlead
- Centre Hospitalier Victor Dupouycollaborator
Study Sites (1)
Groupe Hospitalier Paris Saint-Joseph
Paris, 75014, France
Biospecimen
During the inclusion, a 4 ml citrate tube of blood in addition to the usual management assessment and aspiration of tracheal secretions will be performed at D1, D3 and D7. Tracheal aspiration is performed systematically in order to limit patient congestion and the risk of atelectasis.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François PHILLIPART, MD
Fondation Hôpital Saint-Joseph
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2020
First Posted
July 28, 2020
Study Start
September 11, 2020
Primary Completion
September 10, 2022
Study Completion
April 30, 2023
Last Updated
March 7, 2023
Record last verified: 2023-03